Interplay between brain-specific microRNAs and Alzheimer's disease

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by memory loss and brain protein aggregates.
• The exact causes of AD are still being researched, but microRNAs (miRs) are implicated in its development.
• Brain-specific miRs are vital for central nervous system function and neuronal development.

Purpose of the Study:

• To review key brain-specific microRNAs (miRs) involved in Alzheimer's disease (AD) pathogenesis.
• To explore the localization, dysregulation, and functional roles of these miRs in AD.
• To highlight the potential of miRs as biomarkers for AD diagnosis and progression monitoring.

Main Methods:

• Literature review of studies on brain-specific microRNAs (miRs) in Alzheimer's disease (AD).
• Identification and analysis of miRs implicated in AD pathogenesis.
• Examination of miR roles in cellular processes relevant to AD.

Main Results:

• Several brain-specific microRNAs (miRs), including miR-9, miR-124, and miR-146a, are dysregulated in Alzheimer's disease (AD).
• These miRs are located in the brain and influence key cellular processes like autophagy, tau phosphorylation, and neuroinflammation.
• Dysregulated miRs modulate genes involved in AD pathology, affecting amyloid-beta production and cell cycle regulation.

Conclusions:

• Brain-specific microRNAs (miRs) are significantly involved in Alzheimer's disease (AD) pathogenesis.
• Dysregulation of these miRs impacts crucial cellular functions, contributing to disease progression.
• miR expression levels show promise as potential biomarkers for early diagnosis and monitoring of Alzheimer's disease.